Physician

Nathaniel Robert Ranney, M.D.

According to 2025 Medicare claims, Nathaniel Ranney, M.D. (NPI: 1366676223) practices gastroenterology in the Slidell-Mandeville-Covington, LA market, with the plurality of this provider's patient population coming from St. Tammany, LA. This provider's primary affiliated billing organization is TEXAS DIGESTIVE DISEASE CONSULTANTS PLLC (NPI: 1295428415; TIN: 752005254) and primary practice location at 70433-7244. Ranney is affiliated with the Ochsner Accountable Care Network, LLC (ACO ID: A1535), participating under the MSSP model.

Ranney's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 417 traditional Medicare patients, billed 5,171 HCPCS/CPT codes, and received $136,699 in Medicare payments. The top billing code was 45385 (Removal of polyps or growths of large bowel using an endoscope with mechanical snare). Part D data shows 1,577 prescription claims across 427 beneficiaries totaling $687,971 in drug costs, led by Creon (Lipase/Protease/Amylase). 2020 DME data shows 11 claims. Open Payments data shows 238 records totaling $79,463. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $59,000 to $136,699. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $515,214 and ending at $687,971. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	330	652	$59,000
2016	504	1,228	$96,340
2017	450	1,092	$90,806
2018	486	1,523	$115,287
2019	460	1,465	$113,120
2020	405	1,399	$102,311
2021	425	1,451	$113,102
2022	417	1,801	$103,606
2023	396	4,043	$141,331
2024	417	5,171	$136,699

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	203	564	$515,214
2016	300	1,422	$756,376
2017	342	1,468	$309,067
2018	404	1,869	$468,203
2019	486	1,932	$552,434
2020	453	1,843	$574,587
2021	515	1,851	$716,717
2022	402	1,586	$846,615
2023	449	1,575	$712,901
2024	427	1,577	$687,971

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	24	$2,200
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	11	$1,225
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
45385	Removal of polyps or growths of large bowel using an endoscope with mechanical snare	68	68	$196
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	86	113	$88
45380	Biopsy of large bowel using a flexible endoscope	62	62	$65
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	73	87	$61
43239	Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope	118	118	$46

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Creon	Lipase/Protease/Amylase	65	1,749	$146,452
Rinvoq	Upadacitinib	19	570	$117,452
Linzess	Linaclotide	78	4,260	$73,262
Ibsrela	Tenapanor Hcl	23	750	$43,110
Trulance	Plecanatide	16	480	$8,772

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	237	$79,463	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	1	$9,501	GastroGPO, LLC

Explore More Providers

FAQ

What Medicare data is available for Nathaniel Robert Ranney, M.D.?

Tedicare shows public-source Medicare data for Nathaniel Robert Ranney, M.D. (NPI 1366676223), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Nathaniel Robert Ranney, M.D. have ACO affiliation data?

Nathaniel Robert Ranney, M.D. is shown with ACO affiliation data for Ochsner Accountable Care Network, LLC (MSSP, ACO ID A1535).

What billing organization is linked to Nathaniel Robert Ranney, M.D.?

Nathaniel Robert Ranney, M.D. is linked to TEXAS DIGESTIVE DISEASE CONSULTANTS PLLC (billing NPI 1295428415) in the available physician profile data.

Does Nathaniel Robert Ranney, M.D. have Open Payments data?

Nathaniel Robert Ranney, M.D. has 238 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.